Neuropathology and molecular diagnosis of Synucleinopathies

S Koga, H Sekiya, N Kondru, OA Ross… - Molecular …, 2021 - Springer
Synucleinopathies are clinically and pathologically heterogeneous disorders characterized
by pathologic aggregates of α-synuclein in neurons and glia, in the form of Lewy bodies …

[HTML][HTML] Phase separation and neurodegenerative diseases: a disturbance in the force

A Zbinden, M Pérez-Berlanga, P De Rossi… - Developmental cell, 2020 - cell.com
Protein aggregation is the main hallmark of neurodegenerative diseases. Many proteins
found in pathological inclusions are known to undergo liquid-liquid phase separation, a …

A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research

T Simuni, LM Chahine, K Poston, M Brumm… - The Lancet …, 2024 - thelancet.com
Parkinson's disease and dementia with Lewy bodies are currently defined by their clinical
features, with α-synuclein pathology as the gold standard to establish the definitive …

Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies

G Limorenko, HA Lashuel - Chemical Society Reviews, 2022 - pubs.rsc.org
Converging evidence continues to point towards Tau aggregation and pathology formation
as central events in the pathogenesis of Alzheimer's disease and other Tauopathies …

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

IG McKeith, BF Boeve, DW Dickson, G Halliday… - Neurology, 2017 - AAN Enterprises
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about
the clinical and pathologic diagnosis of DLB, updating the previous report, which has been …

Impact of multiple pathologies on the threshold for clinically overt dementia

A Kapasi, C DeCarli, JA Schneider - Acta neuropathologica, 2017 - Springer
Longitudinal clinical–pathological studies have increasingly recognized the importance of
mixed pathologies (the coexistence of one or more neurodegenerative and cerebrovascular …

Mini‐Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations

ST Creavin, S Wisniewski… - Cochrane Database …, 2016 - cochranelibrary.com
Background The Mini Mental State Examination (MMSE) is a cognitive test that is commonly
used as part of the evaluation for possible dementia. Objectives To determine the diagnostic …

Cognitive training for people with mild to moderate dementia

A Bahar‐Fuchs, A Martyr, AMY Goh… - Cochrane Database …, 2019 - cochranelibrary.com
Background Cognitive impairment, a defining feature of dementia, plays an important role in
the compromised functional independence that characterises the condition. Cognitive …

The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy …

A Van der Perren, G Gelders, A Fenyi, L Bousset… - Acta …, 2020 - Springer
Synucleinopathies, such as Parkinson's disease (PD), multiple system atrophy (MSA), and
dementia with Lewy bodies (DLB), are defined by the presence of α-synuclein (αSYN) …

Dementia with Lewy bodies: an update and outlook

TF Outeiro, DJ Koss, D Erskine, L Walker… - Molecular …, 2019 - Springer
Dementia with Lewy bodies (DLB) is an age-associated neurodegenerative disorder
producing progressive cognitive decline that interferes with normal life and daily activities …